Human Genetics and Genomics Advances
Q1 Journal
Open Access
Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Genetics (clinical)
Q1
└
Molecular Medicine
Q1
Publisher
SJR 2025
1.761
Q1
SJR Score
H-Index
24
Citations / Doc (2yr)
3.24
Total Docs. (latest)
116
Total Citations (3yr)
881
Publication type
Journals
ISSN
26662477
Coverage
2020-2026
Journal Rank
#1,822
Subject Categories
Genetics (clinical)
Q1
Molecular Medicine
Q1
Subject Areas
Aims & Scope
Human Genetics and Genomics Advances is an open-access journal publishing across the complete spectrum of human genetic and genomic research.
Its mission is to build the human genetics and genomics knowledge base.
HGG Advances is a home for human genetics and genomics research characterized by high standards of scientific rigor, validity, and reproducibility.
HGG Advances is an important addition to the American Society of Human Genetics family of journals.
It offers researchers a home for a wide variety of research findings and formats and is committed to prompt dissemination of results through timely peer review, continuous online publication, and innovation in responding to the human genetics and genomics community’s needs as the field evolves.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Medline
PubMed
Embase
Detailed Metrics
| Total Docs. (latest) | 116 |
| Total Docs. (3 years) | 228 |
| Total Refs. | 5,898 |
| Total Citations (3 years) | 881 |
| Citable Docs. (3 years) | 223 |
| Citations / Doc. (2 years) | 3.24 |
| Ref. / Doc. | 50.84 |
| % Female | 50.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.